Navigation Links
Ranbaxy and Pfizer Settle Lipitor Litigation Worldwide
Date:6/18/2008

Ranbaxy Will Market Generic Atorvastatin in the U.S. With 180 Days

Exclusivity From Nov. 30, 2011

Agreement Also Resolves Caduet, Accupril Litigation in the US

GURGAON, Harayana, India and PRINCETON, N.J., June 18 /PRNewswire/ -- Ranbaxy Laboratories Limited (Ranbaxy), announced today that it has entered into an agreement with Pfizer Inc. to settle most of the patent litigation worldwide involving Atorvastatin (Lipitor), the world's most-prescribed cholesterol-lowering medicine. This decision will allow for an earlier introduction of a generic formulation that will benefit patients and many healthcare systems throughout the world. Lipitor is the world's largest selling drug with worldwide sales in 2007 of $12.7 billion.

The agreement pertains solely to Ranbaxy and its affiliates and does not cover legal challenges to the Lipitor patents involving other generic manufacturers. However, as Ranbaxy was the first generic challenger to the listed Lipitor patents, it retains the right to the marketing exclusivity of 180 days in the United States. Under the terms of the agreement, Ranbaxy will have a license to sell generic versions of Atorvastatin and the fixed-dose combination of Atorvastatin-Amlodipine besylate in the United States effective Nov. 30, 2011.

Welcoming the development, Malvinder Mohan Singh, CEO and MD, Ranbaxy Laboratories Ltd., said, "This comprehensively settles outstanding issues between Ranbaxy and Pfizer bringing to closure a number of ongoing patent disputes. It also provides certainty and visibility to the launch of Ranbaxy's Generic Atorvastatin, with 180-day market exclusivity in the US and an early entry in other markets. This will make the worlds largest selling drug more accessible to patients who will gain from the timely availability of an affordable quality option."

Ranbaxy will also have a license to sell Atorvastatin on varying dates in an additional 7 countries, includi
'/>"/>

SOURCE Ranbaxy Laboratories Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Ranbaxy to Bring in Daiichi Sankyo as Majority Partner; Strategic Combination Creates Innovator and Generic Pharma Powerhouse
2. Ranbaxy Receives Final Approval to Manufacture and Market Cetirizine Hydrochloride Oral Solution
3. Ranbaxy Gains Approval to Manufacture and Market Cefuroxime Axetil for Oral Suspension
4. Ranbaxy Receives Final Approval to Manufacture and Market Cetirizine Hydrochloride Tablets (OTC), 5mg and 10mg
5. Ranbaxy Receives Tentative Approval For Valsartan Tablets
6. Ranbaxy First to Gain Approval to Manufacture and Market Clarithromycin for Oral Suspension, USP
7. Ranbaxy Gains Approval to Manufacture and Market Carvedilol Tablets in the U.S. Market
8. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
9. Novartis, Pfizer and Merck Take the Lead on Strong Relationships with Physicians, as Doctors Demand an Expanding Set of Services
10. Pfizers work on penicillin for World War II becomes a National Historic Chemical Landmark
11. AUDIO from Medialink and Pfizer: Free Programs for Uninsured Men and Women Who Need Help Paying for Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2015)... VA (PRWEB) May 30, 2015 ... Foundation interviewed Dr. Charles Simone and Dr. Evan ... during its ‘Meet the Mesothelioma Experts’ series. The ... focusing on mesothelioma centers of excellence. Drs. Simone ... executive director, Mary Hesdorffer, with whom they discussed ...
(Date:5/30/2015)... Nicole Blodgett, Vice President of Secura ... designation to further her expertise in the income ... insurance advisors, health care professionals, and financial planners ... associated with the risk and the cost with ... the latest accomplishment in Nicole's journey with Secura ...
(Date:5/30/2015)... San Luis Obispo, CA (PRWEB) May 30, 2015 ... Susan Polk announced today that she is offering a ... insurance. , The offer coincides with Disability Awareness ... Life Happens . Industry members across the United States ... as a time to raise awareness about the possibility ...
(Date:5/30/2015)... (PRWEB) May 30, 2015 A live ... of medical equipment from hospitals, surgery centers and other ... equipment will be sold including radiology, surgery, endoscopy, lab, ... auction will take place Tuesday, June 2nd starting at ... warehouse located at 5025 North Hiatus Rd., Sunrise, FL ...
(Date:5/29/2015)... 29, 2015 Based in St. Louis, Missouri ... shirts for a couple of months now and are ... release, which reads “I’m not misbehaving, I have Autism, please ... parent’s of an autistic child in order to start a ... Not only are they raising awareness through the autism awareness ...
Breaking Medicine News(10 mins):Health News:Interview with Mesothelioma Experts, Drs. Simone and Alley Now Available on Demand 2Health News:Secura Consultants Expands Disability Insurance Expertise 2Health News:San Luis Obispo Insurance Agent Susan Polk Offering Complementary Insurance Analysis In Honor Of Disability Awareness Month 2Health News:Centurion to Sell Surplus Medical Equipment in Online and On-site Auction 2Health News:La La Land Shirts Is Busy Spreading Autism Awareness with Complimentary Shipping on Their New Shirt 2
... to ... the Rules for Healthcare Payors, BURLINGTON, Mass., April ... benefit administration, business,intelligence and portal software products for healthcare ... investment commitment from,Psilos Group, a leading healthcare venture capital ...
... XR, Will Earn a 16 Percent Patient Share in the Bipolar ... ... Decision Resources, WALTHAM, Mass., April 22 Decision Resources, one of ... that a therapy that carries a lower risk of weight,gain than AstraZeneca,s ...
... Diversified Agency Services, a,division of Omnicom Group Inc. ... healthcare and pharmaceutical agencies Cline Davis Mann, Corbett and,Flashpoint ... at the 19th Annual,Manny Awards., Cline Davis Mann ... all,agencies with annual revenue of more than $50 million. ...
... MONICA, Calif., April 22 Aida,Pharmaceuticals, Inc. ... of an investor-focused corporate synopsis on its ... be downloaded as a,pdf document. The synopsis ... current product line, the drugs in its,development ...
... 22 WallSt.net,s 3-Minute,Press Show is a daily ... Shows air Monday through Friday on:, http://tv.wallst.net/3-min-press/3-min-press.php ... interviews with,public company executives on their company and ... provide viewers with insight into a company,s most,recent ...
... American College of Allergy,Asthma & Immunology (ACAAI) recently ... highlight the importance of improving care for those,who ... important,information for physicians and patients are available today ... who are,committed to driving the dialogue about unmet ...
Cached Medicine News:Health News:HealthEdge Receives $13 Million Investment Commitment to Fund Significant Growth 2Health News:A Drug That Carries a Lower Risk of Weight Gain Than AstraZeneca's Seroquel and Has Antimanic and Antidepressant Effects Would Earn a 30 Percent Patient Share in Bipolar Disorder Treatment 2Health News:Omnicom's Diversified Agency Services Healthcare Agencies Top Med Ad News' Manny Awards 2Health News:Aida Pharmaceuticals, Inc. Announces Availability of Downloadable Corporate Synopsis on its Website 2Health News:Featured Stocks on Today's Edition of WallSt.net's 3-Minute Press Show: CYRX, RHWI 2
(Date:5/29/2015)... 29, 2015  The annual customer satisfaction survey of ... EMR as #1 across all specialties. Every year, ... conducts a poll of EHR users and publishes an ... Praxis EMR topped 348 other systems, ... based criteria used by Black Book. In addition to ...
(Date:5/29/2015)... DIEGO and BOSTON , ... leader in instrument development, custom automation, and contract manufacturing, ... of the Nanopatch™ needle-free drug delivery technology, have been ... development of the Nanopatch Jet Coating Instrument , ... delivery research and product development.  The award was announced ...
(Date:5/29/2015)...  Haemonetics Corporation (NYSE: HAE ) announced today ... present at the JMP Securities Life Sciences Conference in ... rd , 2015 at 11:30am Eastern time.  ... via webcast at: http://wsw.com/webcast/jmp27/hae ... a global healthcare company dedicated to providing innovative blood ...
Breaking Medicine Technology:Praxis EMR Ranks #1 for Physician Satisfaction in Black Book's 2015 Survey of Solo and Small Practices 2Invetech And Vaxxas Named Recipients Of The 2015 Good Design Award For Development Of Nanopatch Jet Coating Instrument For Needle-Free Drug Delivery 2Invetech And Vaxxas Named Recipients Of The 2015 Good Design Award For Development Of Nanopatch Jet Coating Instrument For Needle-Free Drug Delivery 3
... June 23, 2011 ULURU Inc. (NYSE AMEX: ... Gilford Securities Incorporated ("Gilford") to serve as the Company,s financial ... banking services and is a full service national investment firm ... engagement includes assisting the Company to broaden its investor base ...
...   MacroGenics, Inc., a privately held biotechnology company that ... diseases, today announced that 1-year data from Protege, the ... 1 diabetes patients, will be presented at the American ... California on June 28, 2011 at 9:10 a.m. PDT. ...
Cached Medicine Technology:ULURU Inc. Announces the Engagement of Gilford Securities Incorporated to Serve as the Company's Financial Advisor 2MacroGenics Announces Presentation of Protege Phase 3 Clinical Data at ADA in San Diego on June 28 2
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
This dissector offers dual-action jaws, which are long, tapered, and angled 30 to simplify even difficult laparoscopic dissection....
Medicine Products: